Both in Pharmaceuticals
Vertex Pharmaceuticals vs ABBVIE
Over the past year VRTX returned +25.7% and ABBV returned +36.1%; their daily moves had a correlation of 0.50.
VRTX +25.7% ABBV +36.1%Growth of $1, one year, split-adjusted
| Metric | VRTX | ABBV |
|---|---|---|
| Price | $535.34 | $288.53 |
| Market cap | $135.69B | $509.86B |
| Today | −3.22% | −0.11% |
| 1 month | +6.3% | +8.6% |
| 6 months | +26.2% | +40.0% |
| Year to date | +18.1% | +26.3% |
| 1 year | +25.8% | +32.3% |
| Revenue growth (YoY) | +12.5% | +10.2% |
| Gross margin | 85.3% | 74.7% |
| Net margin | 33.0% | 21.3% |
| P/E (TTM) | 30.8× | 81.1× |
| Price / sales | 10.8× | 7.9× |
| Net cash | $7.85B | -$64.25B |
| Dividend yield | — | 2.40% |
| Volatility (60d) | 27.1% | 20.2% |
| Short % of float | 1.7% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).